menu search

IART / Integra's (IART) SIA Buyout Widens Breast Reconstruction Scope

Integra's (IART) SIA Buyout Widens Breast Reconstruction Scope
With the acquisition, SIA's DuraSorb's resorbable synthetic technology is expected to strengthen Integra's (IART) plastic and reconstructive surgery portfolio. Read More
Posted: Dec 13 2022, 12:02
Author Name: Zacks Investment Research
Views: 111859

IART News  

Integra LifeSciences Holdings Corporation (IART) Q3 2023 Earnings Call Transcript

By Seeking Alpha
October 25, 2023

Integra LifeSciences Holdings Corporation (IART) Q3 2023 Earnings Call Transcript

Integra LifeSciences Holdings Corporation (NASDAQ:IART ) Q3 2023 Earnings Call October 25, 2023 8:30 AM ET Company Participants Chris Ward - Senior Di more_horizontal

Integra LifeSciences (IART) Q3 Earnings and Revenues Miss Estimates

By Zacks Investment Research
October 25, 2023

Integra LifeSciences (IART) Q3 Earnings and Revenues Miss Estimates

Integra LifeSciences (IART) came out with quarterly earnings of $0.76 per share, missing the Zacks Consensus Estimate of $0.78 per share. This compare more_horizontal

IART vs. IDXX: Which Stock Is the Better Value Option?

By Zacks Investment Research
October 13, 2023

IART vs. IDXX: Which Stock Is the Better Value Option?

Investors interested in Medical - Instruments stocks are likely familiar with Integra LifeSciences (IART) and Idexx Laboratories (IDXX). But which of more_horizontal

Here's Why Investors Should Retain Integra (IART) Stock Now

By Zacks Investment Research
October 5, 2023

Here's Why Investors Should Retain Integra (IART) Stock Now

International expansion and the strong prospects of the CSS segment bode well for Integra (IART). more_horizontal

Integra LifeSciences to Present at the 2023 Wells Fargo Healthcare Conference

By GlobeNewsWire
September 1, 2023

Integra LifeSciences to Present at the 2023 Wells Fargo Healthcare Conference

PRINCETON, N.J., Sept. 01, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology comp more_horizontal

Here's Why You Should Retain Integra (IART) Stock for Now

By Zacks Investment Research
August 31, 2023

Here's Why You Should Retain Integra (IART) Stock for Now

Investors continue to be optimistic about Integra (IART) based on the prospects of its CSS segment and a stable liquidity position. more_horizontal

Why Is Integra (IART) Down 7.9% Since Last Earnings Report?

By Zacks Investment Research
August 25, 2023

Why Is Integra (IART) Down 7.9% Since Last Earnings Report?

Integra (IART) reported earnings 30 days ago. What's next for the stock? more_horizontal

Integra (IART) CSS Sales Aid, Boston Recall Hurts Growth

By Zacks Investment Research
August 25, 2023

Integra (IART) CSS Sales Aid, Boston Recall Hurts Growth

In spite of facing foreign exchange fluctuations across its non-U.S. business, Integra (IART) is successfully broadening its international footprint. more_horizontal


Search within

Pages Search Results: